These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9160680)

  • 1. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: participation of lysosomes.
    Hurwitz SJ; Terashima M; Mizunuma N; Slapak CA
    Blood; 1997 May; 89(10):3745-54. PubMed ID: 9160680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells.
    Slapak CA; Mizunuma N; Kufe DW
    Blood; 1994 Nov; 84(9):3113-21. PubMed ID: 7949184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts.
    Slapak CA; Lecerf JM; Daniel JC; Levy SB
    J Biol Chem; 1992 May; 267(15):10638-44. PubMed ID: 1350280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
    Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of intracellular organelles implicated in daunorubicin cytoplasmic sequestration in multidrug-resistant MCF-7 cells using fluorescence microscopy image analysis.
    Bour-Dill C; Gramain MP; Merlin JL; Marchal S; Guillemin F
    Cytometry; 2000 Jan; 39(1):16-25. PubMed ID: 10655559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-glycoprotein mediates drug resistance via a novel mechanism involving lysosomal sequestration.
    Yamagishi T; Sahni S; Sharp DM; Arvind A; Jansson PJ; Richardson DR
    J Biol Chem; 2013 Nov; 288(44):31761-71. PubMed ID: 24062304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug sequestration in cytoplasmic organelles does not contribute to the diminished sensitivity of anthracyclines in multidrug resistant K562 cells.
    Loetchutinat C; Priebe W; Garnier-Suillerot A
    Eur J Biochem; 2001 Aug; 268(16):4459-67. PubMed ID: 11502206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
    Cleary I; Doherty G; Moran E; Clynes M
    Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resistant human leukemic cell line HL-60.
    Gong Y; Duvvuri M; Krise JP
    J Biol Chem; 2003 Dec; 278(50):50234-9. PubMed ID: 14522995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification by brefeldin A, bafilomycin A1 and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD) of cellular accumulation and intracellular distribution of anthracyclines in the non-P-glycoprotein-mediated multidrug-resistant cell line COR-L23/R.
    Rhodes T; Barrand MA; Twentyman PR
    Br J Cancer; 1994 Jul; 70(1):60-6. PubMed ID: 7912544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cellular accumulation and cytotoxicity of liposomal and conventional formulations of daunorubicin and doxorubicin in resistant K562 cells.
    Wang Y; Eksborg S; Lewensohn R; Lindberg A; Liliemark E
    Anticancer Drugs; 1999 Nov; 10(10):921-8. PubMed ID: 10630360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the subcellular localization of daunorubicin in multidrug-resistant K562 cell line.
    Gong Y; Wang Y; Chen F; Han J; Miao J; Shao N; Fang Z; Ou Yang R
    Leuk Res; 2000 Sep; 24(9):769-74. PubMed ID: 10978781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal accumulation of drugs in drug-sensitive MES-SA but not multidrug-resistant MES-SA/Dx5 uterine sarcoma cells.
    Wang E; Lee MD; Dunn KW
    J Cell Physiol; 2000 Aug; 184(2):263-74. PubMed ID: 10867652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
    Lehne G; Mørkrid L; den Boer M; Rugstad HE
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 4'-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells.
    Brooks TA; O'Loughlin KL; Minderman H; Bundy BN; Ford LA; Vredenburg MR; Bernacki RJ; Priebe W; Baer MR
    Invest New Drugs; 2007 Apr; 25(2):115-22. PubMed ID: 17072745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells.
    Lautier D; Bailly JD; Demur C; Herbert JM; Bousquet C; Laurent G
    Int J Cancer; 1997 Apr; 71(2):292-9. PubMed ID: 9139856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
    Michieli M; Michelutti A; Damiani D; Pipan C; Raspadori D; Lauria F; Baccarani M
    Leuk Lymphoma; 1993 Feb; 9(3):255-64. PubMed ID: 8097129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells.
    Seidel A; Hasmann M; Löser R; Bunge A; Schaefer B; Herzig I; Steidtmann K; Dietel M
    Virchows Arch; 1995; 426(3):249-56. PubMed ID: 7773504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
    Ax W; Soldan M; Koch L; Maser E
    Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.